Days went by and the girl's doctors never figured out what was wrong. When she was transferred to a different hospital, however, the issue was quickly identified and corrected.
“Many within the healthcare industry believe that cardiovascular care will be increasingly delivered in non-traditional ambulatory settings,” according to one author. “The cardiovascular care community must consider and prepare for this eventuality."
The two anticoagulants are associated with similar mortality rates. However, a new meta-analysis in Circulation may have cardiologists favoring bivalirudin over heparin.
Novo Nordisk is working with Valo Health to identify potential new treatments for cardiometabolic conditions. If it proves to be a fruitful collaboration, the initial payment of $60 million will be just the beginning.
Follow-up care after a successful heart transplant can be challenging—both for providers and their patients. Consider, for example, the fact that so many patients who develop complications never actually present with symptoms.
